Annual Results 2022 - Feb 01, 2023
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.5 MB)
Webcast and presentation
Download the presentation (PDF 5.1 MB)
Download the podcast (MP3 45 MB)
Read the presentation transcript
Novartis ESG Update Q4 2022 (PDF 0.9 MB)
Annual Report and US Securities & Exchange Commission Form 20-F
These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission (SEC) in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.
Download the Novartis Annual Report 2022 (SIX filing) (PDF 3.9 MB)
Download the Novartis Form 20-F/A 2022 (SEC filing) (PDF 3.8 MB)
To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form.